share_log

科濟藥業-B：截至2023年12月31日止月份之股份發行人的證券變動月報表

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 5 05:46
Summary by Moomoo AI
科濟藥業-B（股份代號02171）於2024年1月5日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份內未有變動，維持在200,000,000,000股，每股面值0.00000025美元，總額50,000美元。根據2019年股權激勵計劃及2021年4月30日通過的首次公開發售後受限制股份單位計劃，公司本月底可能發行的新股份數量為3,802,386股。本月內已發行的新股份數目為10,971股。報告中確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
科濟藥業-B（股份代號02171）於2024年1月5日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份內未有變動，維持在200,000,000,000股，每股面值0.00000025美元，總額50,000美元。根據2019年股權激勵計劃及2021年4月30日通過的首次公開發售後受限制股份單位計劃，公司本月底可能發行的新股份數量為3,802,386股。本月內已發行的新股份數目為10,971股。報告中確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
KOCHI PHARMACEUTICAL-B (SHARE CODE 02171) FILED WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 JANUARY 2024 THE REPORT OF CHANGES IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023. The report showed that the company's regulated/registered share capital and issued shares remained unchanged during the month at 200,000,000,000 shares with a face value of $0.000025 per share for a total of $50,000. Under the Equity Incentive Plan 2019 and the Restricted Share Unit Plan after the Initial Public Offering on April 30, 2021, the number of new shares that may be issued by the Company at the end of this month is 3,802,386 shares. The number of new shares issued during the month was 10,971 shares. The report confirms that all securities issuance has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
KOCHI PHARMACEUTICAL-B (SHARE CODE 02171) FILED WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 JANUARY 2024 THE REPORT OF CHANGES IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023. The report showed that the company's regulated/registered share capital and issued shares remained unchanged during the month at 200,000,000,000 shares with a face value of $0.000025 per share for a total of $50,000. Under the Equity Incentive Plan 2019 and the Restricted Share Unit Plan after the Initial Public Offering on April 30, 2021, the number of new shares that may be issued by the Company at the end of this month is 3,802,386 shares. The number of new shares issued during the month was 10,971 shares. The report confirms that all securities issuance has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more